Valuation
HealthcareLive · Yahoo FinancePrice
$27.17
52-Week Range
Decision Context
Altman Z-Score indicates financial distress risk. Review debt levels and cash runway before any position sizing decision.
Based on filing period ending Mar 2026
FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.
Macro Context
SWOT Analysis — HIMS
Inflationary BoomStrengths
Total Assets: $2.2B (+204.5% YoY) — Total assets grew 205% — the company's resource base expanded.
Revenue: $2.3B (+59.0% YoY) — Revenue grew 59% — the company sold more goods or services than the prior year.
Gross Profit: $1.7B (+47.8% YoY) — Gross profit rose 48% — the spread between revenue and direct costs improved.
Operating Cash Flow: $300.0M (+19.5% YoY) — Operating cash flow grew 19% — the business generated more cash from day-to-day operations.
Weaknesses
EPS (Diluted): $0.51 (-3.8% YoY) — Earnings per share fell 4%.
Gross margin narrowed by 5.6pp — worth monitoring for further cost pressure.
Opportunities
No clear opportunities identified at this time.
Threats
Total liabilities represent 75% of total assets — elevated leverage that amplifies both gains and losses.
Financial Charts
Revenue vs Net Income
Gross Profit vs Operating Income
Margin Trend
Operating Cash Flow
Year-over-Year Changes
Total Assets
$2.2B
was $707.5M
Total assets grew 205% — the company's resource base expanded.
Revenue
$2.3B
was $1.5B
Revenue grew 59% — the company sold more goods or services than the prior year.
Gross Profit
$1.7B
was $1.2B
Gross profit rose 48% — the spread between revenue and direct costs improved.
Operating Cash Flow
$300.0M
was $251.1M
Operating cash flow grew 19% — the business generated more cash from day-to-day operations.
EPS (Diluted)
$0.51
was $0.53
Earnings per share fell 4%.
Risk Flags
0 high · 1 medium · 1 low- ◈ Medium
Total liabilities represent 75% of total assets — elevated leverage that amplifies both gains and losses.
- ○ Low
Gross margin narrowed by 5.6pp — worth monitoring for further cost pressure.
Price History
Technical Signals
Daily closes · 1-year dataLatest News
via FinnhubGet the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Trade HIMS
Links open broker research pages. Not an endorsement or recommendation.
Research HIMS & HERS HEALTH, INC.
Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.